Skip to main content

APO MYC500 (Mycophenolate Mofetil 500 mg)

Pill with imprint APO MYC500 is Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Apotex Corp.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO MYC500

Mycophenolate Mofetil

Imprint
APO MYC500
Strength
500 mg
Color
Purple
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
Inactive Ingredients
croscarmellose sodium, magnesium stearate, ferric oxide red, titanium dioxide, ferrosoferric oxide, microcrystalline cellulose, silicon dioxide, hypromelloses, hydroxypropyl cellulose, propylene glycol

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
60505-2967 (Discontinued) Apotex Corp.
68084-0588 (Discontinued) Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.